cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA758198 | .a | 1463 to 2036 | 574 to 1 | 574/574 (100 %) | 0 diff (100 %id) | ||||
AA769950 | .a | 1412 to 1833 | 425 to 4 | 422/425 (99 %) | 0 diff (100 %id) | ||||
AA759119 | .a | 1684 to 2036 | 353 to 1 | 353/353 (100 %) | 7 diff (98.1 %id) | ||||
AA758729 | .a | 1417 to 1833 | 420 to 4 | 417/420 (99 %) | 0 diff (100 %id) | ||||
AA095371 | .a | 592 to 770 | 1 to 177 | 177/209 (84 %) | 13 diff (93.8 %id) | ||||
AA332989 | Embryo, 8 weeks | .d-u | 664 to 874 | 1 to 213 | 213/213 (100 %) | 4 diff (98.2 %id) | |||
AV702713 | adrenal gland | .a | 1663 to 2033 | 1 to 371 | AAA | 371/371 (100 %) | 0 diff (100 %id) | ||
AF091034 | colon carcinoma | .a | 39 to 1766 | 1 to 1728 | 1728/1728 (100 %) | 10 diff (99.5 %id) | |||
AF125104 | .a | 859 to 2031 | 2140 to 967 | Submitted on the opposite strand | 1174/2591 (45 %) | 0 diff (100 %id) | |||
AI903061 | breast | .b | 596 to 1123 | 1 to 528 | tiling clone, | 528/534 (98 %) | 4 diff (99.3 %id) | ||
AK054767 | cerebellum | .a | 5808 to 7803 | 1 to 1994 | available from FLJ, | 1994/1994 (100 %) | 4 diff (99.8 %id) | ||
AK091180 | tongue, tumor tissue | .a | 266 to 2546 | 1 to 2281 | available from FLJ, | 2281/2281 (100 %) | 8 diff (99.7 %id) | ||
AW365034 | denis_drash | .a | 1574 to 1736 | 1 to 163 | 163/163 (100 %) | 3 diff (98.2 %id) | |||
AW368543 | head_neck | .a | 497 to 1072 | 604 to 22 | 583/604 (96 %) | 10 diff (98.4 %id) | |||
AW374938 | colon | .d-u | 687 to 912 | 1 to 228 | 228/228 (100 %) | 11 diff (95.2 %id) | |||
AW859227 | colon | .d-u | 749 to 1124 | 15 to 388 | 374/388 (96 %) | 11 diff (97.2 %id) | |||
AW859636 | colon | .d-u | 756 to 1114 | 1 to 357 | AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 357/357 (100 %) | 12 diff (96.7 %id) | |
AW970819 | .d-u | 1698 to 1995 | 302 to 5 | Submitted on the opposite strand | 298/302 (98 %) | 0 diff (100 %id) | |||
BC015710 | Uterus, leiomyosarcoma | .a | 95 to 1834 | 1 to 1740 | tiling clone, available from MGC, AAA | 1740/1740 (100 %) | 0 diff (100 %id) | ||
BC063457 | Colon, Kidney, Stomach, adult, whole pooled | .a | 36 to 1833 | 1 to 1798 | available from MGC, AAA | 1798/1798 (100 %) | 0 diff (100 %id) | ||
BE093826 | breast | .e-u | 329 to 706 | 1 to 378 | tiling clone, | 378/378 (100 %) | 1 diff (99.8 %id) | ||
BE147936 | head_neck | .a | 589 to 770 | 1 to 185 | 185/190 (97 %) | 13 diff (93.2 %id) | |||
BE169191 | head_neck | .a | 837 to 1063 | 252 to 26 | Submitted on the opposite strand | 227/252 (90 %) | 0 diff (100 %id) | ||
BE169220 | head_neck | .a | 837 to 1063 | 252 to 26 | Submitted on the opposite strand | 227/252 (90 %) | 0 diff (100 %id) | ||
BE774830 | uterus | .d-u | 159 to 586 | 428 to 2 | 427/474 (90 %) | 0 diff (100 %id) | |||
BF095666 | uterus_tumor | .d-u | 1410 to 1682 | 1 to 274 | 274/274 (100 %) | 1 diff (99.7 %id) | |||
BF095740 | uterus_tumor | .d-u | 1411 to 1682 | 272 to 1 | 272/290 (93 %) | 5 diff (98.3 %id) | |||
BF149423 | skin | .a | 632 to 1078 | 448 to 1 | 448/448 (100 %) | 1 diff (99.8 %id) | |||
BF327182 | breast_normal | .a | 1098 to 1334 | 240 to 5 | 236/240 (98 %) | 0 diff (100 %id) | |||
BF331861 | breast | .a | 920 to 1221 | 304 to 2 | 303/304 (99 %) | 0 diff (100 %id) | |||
BF365818 | nervous_tumor | .a | 393 to 786 | 1 to 395 | 395/395 (100 %) | 6 diff (98.5 %id) | |||
BF752632 | breast_normal | .a | 6479 to 6821 | 355 to 13 | Submitted on the opposite strand | 343/372 (92 %) | 0 diff (100 %id) | ||
BF934736 | nervous_tumor | .b | 551 to 917 | 1 to 367 | 367/367 (100 %) | 1 diff (99.8 %id) | |||
BG196829 | .a | 763 to 1521 | 1 to 759 | 759/759 (100 %) | 8 diff (99.0 %id) | ||||
BG461740 | .a | 3415 to 3981 | 1 to 582 | tiling clone, | 582/588 (98 %) | 31 diff (94.8 %id) | |||
BQ316058 | colon | .a | 312 to 738 | 429 to 1 | 429/429 (100 %) | 6 diff (98.7 %id) | |||
DA055460 | cerebellum | .a | 5809 to 6365 | 2 to 557 | capped | 556/556 (100 %) | 3 diff (99.5 %id) | ||
DB296537 | cerebellum | .a | 7265 to 7803 | 541 to 1 | 541/541 (100 %) | 4 diff (99.3 %id) | |||
DA110755 | cerebellum | .a | 3845 to 4090 | 2 to 248 | capped | 247/247 (100 %) | 2 diff (99.2 %id) | ||
DA145162 | amygdala | .a | 6184 to 6757 | 2 to 576 | capped | 575/575 (100 %) | 2 diff (99.7 %id) | ||
DA155190 | amygdala | .a | 6269 to 6836 | 2 to 569 | capped | 568/568 (100 %) | 1 diff (99.9 %id) | ||
DA243569 | brain | .a | 4852 to 5431 | 2 to 582 | capped | 581/581 (100 %) | 3 diff (99.5 %id) | ||
DA249499 | brain | .a | 3517 to 4090 | 2 to 575 | capped | 574/574 (100 %) | 2 diff (99.7 %id) | ||
DA288741 | hippocampus | .a | 6368 to 6911 | 2 to 545 | capped | 544/544 (100 %) | 0 diff (100 %id) | ||
DA301659 | hippocampus | .a | 4402 to 4945 | 2 to 546 | capped | 545/545 (100 %) | 1 diff (99.9 %id) | ||
DB308051 | hippocampus | .a | 7278 to 7804 | 533 to 5 | 529/533 (99 %) | 0 diff (100 %id) | |||
DA316627 | hippocampus | .a | 3688 to 4244 | 2 to 558 | tiling clone, capped | 557/557 (100 %) | 2 diff (99.7 %id) | ||
DA317564 | hippocampus | .a | 5045 to 5592 | 2 to 549 | capped | 548/548 (100 %) | 1 diff (99.9 %id) | ||
DA389016 | thalamus | .a | 5866 to 6458 | 2 to 594 | capped | 593/593 (100 %) | 0 diff (100 %id) | ||
DA404250 | thalamus | .a | 4714 to 5280 | 2 to 568 | capped | 567/567 (100 %) | 0 diff (100 %id) | ||
DA415570 | thalamus | .a | 5298 to 5891 | 2 to 595 | capped | 594/594 (100 %) | 1 diff (99.9 %id) | ||
BT007046 | .a | 282 to 864 | 1 to 583 | 583/585 (99 %) | 1 diff (99.9 %id) | ||||
BX102853 | liver and spleen | .d-u | 602 to 1097 | 1 to 496 | 496/496 (100 %) | 0 diff (100 %id) | |||
BX113476 | placenta | .a | 1116 to 1885 | 1 to 769 | 769/769 (100 %) | 1 diff (99.9 %id) | |||
F01357 | brain, total brain | .a | 1612 to 1833 | 222 to 1 | 222/222 (100 %) | 1 diff (99.6 %id) | |||
F05105 | brain, total brain | .a | 403 to 642 | 1 to 240 | 240/240 (100 %) | 0 diff (100 %id) | |||
F07898 | brain, total brain | .a | 259 to 577 | 1 to 318 | 318/318 (100 %) | 1 diff (99.7 %id) | |||
Z40973 | brain, total brain | .a | 1512 to 1827 | 316 to 1 | 316/316 (100 %) | 0 diff (100 %id) | |||
F04725 | brain, total brain | .a | 1565 to 1827 | 263 to 1 | 263/263 (100 %) | 0 diff (100 %id) | |||
F08512 | brain, total brain | .a | 260 to 566 | 1 to 307 | 307/307 (100 %) | 0 diff (100 %id) | |||
Z41567 | brain, total brain | .d-u | 1706 to 2001 | 296 to 1 | 296/296 (100 %) | 1 diff (99.7 %id) | |||
Z45949 | brain, total brain | .d-u | 456 to 785 | 1 to 330 | 330/330 (100 %) | 1 diff (99.7 %id) | |||
C21443 | .a | 1568 to 1787 | 8 to 227 | 220/227 (96 %) | 6 diff (97.4 %id) | ||||
BP204123 | coronary artery | .a | 675 to 1255 | 1 to 580 | 580/580 (100 %) | 6 diff (99.0 %id) | |||
BP205185 | coronary artery | .a | 1192 to 1769 | 1 to 576 | 576/581 (99 %) | 18 diff (97.0 %id) | |||
CN276883 | embryonic stem cells, DMSO-treated H9 cellline | .d-u | 1059 to 1732 | 1 to 674 | exact | 674/676 (99 %) | 1 diff (99.9 %id) | ||
DA432623 | colon | .a | 42 to 458 | 2 to 419 | capped | 418/418 (100 %) | 1 diff (99.8 %id) | ||
CR610918 | HeLa cells Cot 25-normalized | .a | 75 to 1810 | 1 to 1736 | 1736/1736 (100 %) | 0 diff (100 %id) | |||
BX441328 | brain, fetal brain | .b | 1 to 1032 | 1 to 1021 | G3R P32R P33L L34C R35A ... | tiling clone, | 1021/1021 (100 %) | 14 diff (98.7 %id) | |
BX413168 | brain, fetal brain | .b | 1084 to 1768 | 716 to 30 | tiling clone, | 687/810 (84 %) | 0 diff (100 %id) | ||
AL538045 | brain, fetal brain | .a | 25 to 1136 | 9 to 1110 | P189X C193A | 1102/1110 (99 %) | 22 diff (98.1 %id) | ||
AL567117 | brain, fetal brain | .a | 1164 to 2267 | 1089 to 1 | 1089/1127 (96 %) | 28 diff (97.6 %id) | |||
AL539118 | brain, fetal brain | .a | 880 to 1774 | 906 to 20 | fully sequenced, | 887/906 (97 %) | 32 diff (96.5 %id) | ||
AL539119 | brain, fetal brain | .a | 41 to 910 | 1 to 869 | L11X D28N M73X E91X W99X ... | fully sequenced, | 869/869 (100 %) | 24 diff (97.3 %id) | |
AL557604 | T cells (Jurkat cell line), T cells from T cell leukemia | .a | 65 to 1073 | 1 to 985 | fully sequenced, | 798/798 (100 %) | 45 diff (94.4 %id) | ||
AL579600 | T cells (Jurkat cell line), T cells from T cell leukemia | .a | 1067 to 1967 | 897 to 1 | fully sequenced, | 897/897 (100 %) | 22 diff (97.6 %id) | ||
BX372167 | .a | 395 to 1181 | 793 to 1 | 793/793 (100 %) | 21 diff (97.4 %id) | ||||
BX401201 | .a | 1000 to 1810 | 811 to 1 | 811/811 (100 %) | 13 diff (98.4 %id) | ||||
BX401202 | .a | 75 to 834 | 1 to 759 | 759/759 (100 %) | 1 diff (99.9 %id) | ||||
DA438501 | tongue, tumor tissue | .a | 267 to 848 | 2 to 583 | capped | 582/582 (100 %) | 6 diff (99.0 %id) | ||
DB313526 | tongue, tumor tissue | .a | 2018 to 2546 | 530 to 1 | 530/530 (100 %) | 2 diff (99.7 %id) | |||
CV023277 | mixed | .a | 282 to 872 | 1 to 590 | *195C | 590/638 (92 %) | 4 diff (99.4 %id) | ||
BX477045 | .b | 1645 to 2203 | 1 to 559 | tiling clone, | 559/559 (100 %) | 1 diff (99.9 %id) | |||
AL707403 | human skeletal muscle | .a | 2422 to 3101 | 1 to 680 | tiling clone, | 680/680 (100 %) | 1 diff (99.9 %id) | ||
BX482784 | .a | 5518 to 6046 | 1 to 530 | tiling clone, | 530/530 (100 %) | 2 diff (99.7 %id) | |||
AL121369 | melanoma (MeWo cell line) | .a | 5024 to 5534 | 1 to 513 | 513/513 (100 %) | 2 diff (99.7 %id) | |||
BX645410 | .d-u | 1485 to 2004 | 540 to 21 | tiling clone, | Submitted on the opposite strand | 520/540 (96 %) | 0 diff (100 %id) | ||
DA491715 | brain | .a | 5052 to 5628 | 2 to 579 | capped | 578/578 (100 %) | 2 diff (99.7 %id) | ||
CD672277 | eye, Iris | .a | 640 to 1193 | 1 to 554 | 554/554 (100 %) | 0 diff (100 %id) | |||
FN047533 | breast carcinoma | .a | 865 to 975 | 111 to 1 | Submitted on the opposite strand | 111/111 (100 %) | 1 diff (99.1 %id) | ||
FN090674 | breast carcinoma | .a | 1724 to 1826 | 1 to 104 | 104/109 (95 %) | 2 diff (98.2 %id) | |||
FN090928 | breast carcinoma | .a | 843 to 939 | 97 to 1 | Submitted on the opposite strand | 97/97 (100 %) | 0 diff (100 %id) | ||
FN124991 | breast carcinoma | .a | 2154 to 2281 | 1 to 127 | 127/127 (100 %) | 1 diff (99.3 %id) | |||
FN131707 | breast carcinoma | .a | 1886 to 1999 | 1 to 110 | 110/110 (100 %) | 4 diff (96.4 %id) | |||
DB452461 | testis | .a | 20 to 500 | 1 to 481 | 481/481 (100 %) | 0 diff (100 %id) | |||
DB462278 | testis | .a | 20 to 487 | 1 to 468 | 468/468 (100 %) | 0 diff (100 %id) | |||
DB527714 | testis | .a | 1380 to 1834 | 1 to 455 | Submitted on the opposite strand | 455/455 (100 %) | 0 diff (100 %id) | ||
DB533250 | hippocampus | .a | 2504 to 2893 | 1 to 392 | Submitted on the opposite strand | 392/392 (100 %) | 7 diff (98.3 %id) | ||
DB502657 | hypothalamus | .a | 1567 to 2034 | 1 to 468 | 468/468 (100 %) | 0 diff (100 %id) | |||
DB573885 | hypothalamus | .a | 2159 to 2616 | 1 to 458 | tiling clone, | Submitted on the opposite strand | 458/458 (100 %) | 1 diff (99.8 %id) | |
DA559280 | .a | 6382 to 6902 | 2 to 522 | capped | 521/521 (100 %) | 1 diff (99.9 %id) | |||
BY796673 | eye | .d-u | 1164 to 1714 | 1 to 551 | 551/551 (100 %) | 0 diff (100 %id) | |||
BP250931 | hippocampus | .a | 734 to 1316 | 1 to 583 | 583/583 (100 %) | 11 diff (98.2 %id) | |||
BP251565 | hippocampus | .a | 1457 to 2038 | 1 to 582 | 582/582 (100 %) | 0 diff (100 %id) | |||
DA601919 | .a | 6587 to 7155 | 2 to 571 | capped | 570/570 (100 %) | 1 diff (99.9 %id) | |||
CN484783 | eye | .d-u | 155 to 794 | 1 to 640 | tiling clone, | 640/640 (100 %) | 3 diff (99.6 %id) | ||
T23564 | .a | 1506 to 1835 | 332 to 3 | 330/332 (99 %) | 0 diff (100 %id) | ||||
R39153 | whole brain | .d-u | 1615 to 2001 | 401 to 11 | AAA | 391/400 (97 %) | 13 diff (96.8 %id) | ||
R53346 | whole brain | .a | 404 to 824 | 1 to 431 | 428/432 (99 %) | 23 diff (94.7 %id) | |||
R53949 | whole brain | .a | 1450 to 1833 | 408 to 14 | AAA | 395/438 (90 %) | 12 diff (97.3 %id) | ||
H11062 | whole brain | .d-u | 1538 to 2001 | 485 to 11 | AAA | 475/476 (99 %) | 34 diff (92.9 %id) | ||
H11150 | whole brain | .d-u | 456 to 874 | 1 to 425 | 425/480 (88 %) | 8 diff (98.4 %id) | |||
H12005 | whole brain | .a | 710 to 1120 | 1 to 417 | 417/417 (100 %) | 14 diff (96.7 %id) | |||
H15351 | whole brain | .d-u | 457 to 904 | 1 to 456 | 456/590 (77 %) | 14 diff (97.7 %id) | |||
H23259 | whole brain | .a | 1502 to 1834 | 355 to 13 | AAA | 343/380 (90 %) | 17 diff (95.6 %id) | ||
H23370 | whole brain | .a | 404 to 801 | 1 to 397 | 397/397 (100 %) | 6 diff (98.5 %id) | |||
R01399 | liver and spleen | .d-u | 909 to 1152 | 1 to 249 | 249/249 (100 %) | 6 diff (97.6 %id) | |||
R63940 | placenta | .a | 1753 to 2031 | 279 to 1 | 279/279 (100 %) | 2 diff (99.3 %id) | |||
R64036 | placenta | .a | 1113 to 1572 | 1 to 462 | 462/464 (99 %) | 7 diff (98.5 %id) | |||
R76965 | placenta | .a | 2001 to 2455 | 1 to 458 | 458/463 (98 %) | 7 diff (98.5 %id) | |||
R78918 | placenta | .a | 1575 to 2015 | 446 to 1 | 446/448 (99 %) | 13 diff (97.1 %id) | |||
R79015 | placenta | .a | 1113 to 1260 | 1 to 147 | 147/148 (99 %) | 2 diff (98.7 %id) | |||
R93637 | liver and spleen | .a | 6043 to 6319 | 1 to 285 | fully sequenced, | 285/285 (100 %) | 4 diff (98.6 %id) | ||
R93638 | liver and spleen | .a | 6289 to 6564 | 294 to 1 | fully sequenced, | 294/294 (100 %) | 17 diff (94.3 %id) | ||
N54527 | liver and spleen | .d-u | 1627 to 1997 | 379 to 2 | 378/478 (79 %) | 0 diff (100 %id) | |||
N76230 | liver and spleen | .d-u | 654 to 1051 | 1 to 399 | 399/437 (91 %) | 9 diff (98.0 %id) | |||
H87195 | placenta | .a | 1498 to 1813 | 330 to 2 | 329/331 (99 %) | 0 diff (100 %id) | |||
H87704 | placenta | .a | 697 to 1053 | 31 to 391 | 361/391 (92 %) | 11 diff (97.2 %id) | |||
N22693 | melanocyte | .a | 1406 to 1815 | 422 to 1 | fully sequenced, | 422/422 (100 %) | 10 diff (97.7 %id) | ||
N31167 | melanocyte | .a | 1185 to 1436 | 1 to 252 | fully sequenced, | 252/252 (100 %) | 1 diff (99.7 %id) | ||
N31480 | melanocyte | .d-u | 1593 to 2003 | 413 to 1 | 413/414 (99 %) | 2 diff (99.6 %id) | |||
N42789 | melanocyte | .d-u | 923 to 1407 | 1 to 493 | 493/494 (99 %) | 14 diff (97.2 %id) | |||
N69505 | cochlea, ear | .d-u | 1546 to 2002 | 467 to 5 | 463/478 (96 %) | 0 diff (100 %id) | |||
N73955 | lung | .a | 1688 to 1827 | 140 to 1 | 140/140 (100 %) | 0 diff (100 %id) | |||
N95443 | senescent fibroblast | .d-u | 1584 to 2009 | 423 to 1 | fully sequenced, | 423/423 (100 %) | 7 diff (98.4 %id) | ||
W24323 | senescent fibroblast | .d-u | 1176 to 1614 | 1 to 443 | fully sequenced, | 443/443 (100 %) | 7 diff (98.5 %id) | ||
W69720 | heart | .d-u | 1561 to 2004 | 451 to 4 | 448/455 (98 %) | 0 diff (100 %id) | |||
W69848 | heart | .d-u | 1104 to 1516 | 1 to 415 | 415/415 (100 %) | 2 diff (99.6 %id) | |||
AA025596 | heart | .d-u | 1821 to 2003 | 183 to 1 | 183/183 (100 %) | 2 diff (99.0 %id) | |||
AA005413 | liver and spleen | .d-u | 909 to 1400 | 1 to 499 | 499/500 (99 %) | 11 diff (97.8 %id) | |||
AA005414 | liver and spleen | .d-u | 1616 to 1978 | 368 to 1 | 368/368 (100 %) | 7 diff (98.1 %id) | |||
AA678372 | liver and spleen | .d-u | 1566 to 2004 | 439 to 1 | 439/439 (100 %) | 3 diff (99.4 %id) | |||
AA199604 | .a | 1600 to 1833 | 234 to 1 | 234/234 (100 %) | 0 diff (100 %id) | ||||
AA195101 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 5065 to 5488 | 1 to 422 | fully sequenced, | 422/422 (100 %) | 0 diff (100 %id) | ||
AA195324 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 5458 to 5604 | 147 to 1 | fully sequenced, | 147/147 (100 %) | 0 diff (100 %id) | ||
AA195489 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 859 to 1470 | 14 to 624 | 611/624 (97 %) | 6 diff (99.1 %id) | |||
AA293036 | ovarian tumor, ovary | .a | 640 to 1231 | 1 to 584 | 584/584 (100 %) | 11 diff (98.2 %id) | |||
AA293428 | ovarian tumor, ovary | .a | 1391 to 1827 | 437 to 1 | 437/437 (100 %) | 1 diff (99.8 %id) | |||
AA398963 | .d-u | 1620 to 2004 | 400 to 16 | 385/400 (96 %) | 0 diff (100 %id) | ||||
AA398826. matches multiple genes | .d-u | 754 to 1133 | 11 to 389 | also hits gene rerda | 379/389 (97 %) | 6 diff (98.5 %id) | |||
AA452929 | .a | 1932 to 2291 | 361 to 2 | 360/361 (99 %) | 0 diff (100 %id) | ||||
AA453102 | .a | 323 to 689 | 1 to 367 | 367/367 (100 %) | 1 diff (99.8 %id) | ||||
AA457216 | .a | 1700 to 2034 | 335 to 1 | 335/335 (100 %) | 0 diff (100 %id) | ||||
AA457317 | .a | 842 to 1086 | 1 to 252 | 252/256 (98 %) | 23 diff (91.1 %id) | ||||
AA533608 | colon | .a | 1599 to 2036 | 437 to 3 | 435/446 (97 %) | 0 diff (100 %id) | |||
AA535354 | colon | .a | 1314 to 1827 | 512 to 1 | 512/523 (97 %) | 12 diff (97.8 %id) | |||
AA564406 | colon | .d-u | 1639 to 2003 | 384 to 20 | AAA | 365/365 (100 %) | 4 diff (99.0 %id) | ||
AA522952 | Ewing's sarcoma | .a | 1351 to 1834 | 477 to 1 | 477/499 (95 %) | 15 diff (97.0 %id) | |||
AA526279 | normal prostate, Prostate | .a | 1315 to 1827 | 526 to 13 | AAA | 514/514 (100 %) | 7 diff (98.7 %id) | ||
AA573492 | colon | .a | 1337 to 1827 | 506 to 14 | AAA | 493/493 (100 %) | 3 diff (99.4 %id) | ||
AA554316 | colon | .a | 1500 to 1833 | 334 to 1 | 334/334 (100 %) | 0 diff (100 %id) | |||
AA679966 | .d-u | 1520 to 2002 | 483 to 1 | 483/483 (100 %) | 0 diff (100 %id) | ||||
AA661956 | alveolar rhabdomyosarcoma | .d-u | 1716 to 2004 | 1 to 289 | 289/303 (95 %) | 4 diff (98.7 %id) | |||
AA768243 | germinal center B cell | .d-u | 1592 to 2003 | 424 to 13 | AAA | 412/412 (100 %) | 8 diff (98.1 %id) | ||
AA811935 | germinal center B cell | .d-u | 1058 to 1423 | 371 to 3 | 369/371 (99 %) | 0 diff (100 %id) | |||
AA825202 | germinal center B cell | .a | 2927 to 3401 | 477 to 4 | tiling clone, | 474/479 (98 %) | 0 diff (100 %id) | ||
AA844485 | parathyroid gland, parathyroid tumor | .d-u | 1586 to 2001 | 416 to 1 | 416/416 (100 %) | 0 diff (100 %id) | |||
AA890036 | parathyroid gland, parathyroid tumor | .d-u | 1496 to 2001 | 522 to 17 | AAA | 506/506 (100 %) | 0 diff (100 %id) | ||
AA861702 | .d-u | 1573 to 2004 | 434 to 3 | 432/434 (99 %) | 0 diff (100 %id) | ||||
AA978305 | carcinoid, lung | .a | 1545 to 2030 | 486 to 1 | 486/486 (100 %) | 0 diff (100 %id) | |||
AA932501 | carcinoid, lung | .d-u | 525 to 977 | 1 to 453 | Submitted on the opposite strand | 453/453 (100 %) | 1 diff (99.8 %id) | ||
AI004883 | .d-u | 1612 to 2004 | 395 to 3 | 393/395 (99 %) | 0 diff (100 %id) | ||||
AI005555 | .a | 1439 to 1835 | 397 to 1 | 397/397 (100 %) | 9 diff (97.8 %id) | ||||
AI025683 | .d-u | 700 to 1105 | 406 to 1 | 406/406 (100 %) | 3 diff (99.3 %id) | ||||
AI085275 | B-cell, chronic lymphotic leukemia | .a | 1541 to 1827 | 300 to 14 | AAA | 287/287 (100 %) | 2 diff (99.4 %id) | ||
AI052255 | liver and spleen | .d-u | 1448 to 2003 | 568 to 13 | K18I | AAA | 556/556 (100 %) | 5 diff (99.2 %id) | |
AI080087 | .d-u | 1791 to 2003 | 247 to 35 | AAA | 213/213 (100 %) | 0 diff (100 %id) | |||
AI077565 | .a | 1884 to 2291 | 413 to 6 | 408/413 (98 %) | 0 diff (100 %id) | ||||
AI086375 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 1114 to 1834 | 732 to 15 | AAA | 718/718 (100 %) | 11 diff (98.5 %id) | ||
AI090668 | heart | .a | 1457 to 1827 | 371 to 1 | 371/371 (100 %) | 1 diff (99.8 %id) | |||
AI093452 | uterus | .a | 1382 to 1835 | 455 to 2 | 454/455 (99 %) | 0 diff (100 %id) | |||
AI061173 | .d-u | 1695 to 2003 | 373 to 64 | AAA | 310/321 (96 %) | 0 diff (100 %id) | |||
AI139497 | uterus | .a | 1550 to 2032 | 485 to 3 | 483/485 (99 %) | 0 diff (100 %id) | |||
AI128048 | uterus | .a | 1036 to 1828 | 799 to 4 | 796/806 (98 %) | 0 diff (100 %id) | |||
AI151183 | placenta | .a | 1374 to 1826 | 453 to 1 | 453/453 (100 %) | 0 diff (100 %id) | |||
AI160802 | placenta | .a | 1343 to 1835 | 494 to 2 | 493/494 (99 %) | 0 diff (100 %id) | |||
AI149195 | placenta | .a | 1528 to 1826 | 299 to 1 | 299/299 (100 %) | 1 diff (99.7 %id) | |||
AI271962 | Kidney | .d-u | 1019 to 1415 | 397 to 1 | 397/397 (100 %) | 0 diff (100 %id) | |||
AI245638 | Kidney | .a | 1468 to 1827 | 372 to 12 | AAA | 361/361 (100 %) | 4 diff (98.9 %id) | ||
AI301710 | 2 pooled tumors (clear cell type), Kidney | .a | 1504 to 1829 | 391 to 65 | AAA | 327/327 (100 %) | 11 diff (96.7 %id) | ||
AI310974 | 2 pooled tumors (clear cell type), Kidney | .a | 1577 to 2025 | 460 to 12 | 449/460 (97 %) | 0 diff (100 %id) | |||
AI351641 | .a | 1409 to 1828 | 428 to 9 | 420/428 (98 %) | 0 diff (100 %id) | ||||
AI364410 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .a | 1960 to 2033 | 74 to 1 | 74/74 (100 %) | 0 diff (100 %id) | |||
AI261597 | Kidney | .a | 1459 to 2031 | 574 to 1 | 574/574 (100 %) | 1 diff (99.9 %id) | |||
AI308231 | 2 pooled tumors (clear cell type), Kidney | .d-u | 1567 to 2004 | 443 to 6 | 438/443 (98 %) | 0 diff (100 %id) | |||
AI393755 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 1977 to 2290 | 314 to 1 | 314/314 (100 %) | 0 diff (100 %id) | |||
AI431789 | Kidney | .a | 1572 to 2032 | 463 to 3 | 461/463 (99 %) | 0 diff (100 %id) | |||
AI491878 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .a | 1471 to 1828 | 364 to 7 | 358/364 (98 %) | 0 diff (100 %id) | |||
AI625270 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .d-u | 1813 to 2004 | 192 to 1 | 192/192 (100 %) | 0 diff (100 %id) | |||
AI631177 | pooled germ cell tumors | .a | 1059 to 1834 | 774 to 1 | 774/778 (99 %) | 12 diff (98.5 %id) | |||
AI655727 | pooled germ cell tumors | .d-u | 1567 to 2003 | 450 to 14 | AAA | 437/437 (100 %) | 4 diff (99.1 %id) | ||
AI611688 | poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus | .d-u | 1797 to 2003 | 207 to 1 | 207/207 (100 %) | 0 diff (100 %id) | |||
AI627552 | Kidney | .d-u | 1447 to 2001 | 555 to 1 | exact | 555/555 (100 %) | 0 diff (100 %id) | ||
AI913642 | Kidney | .a | 1471 to 2031 | 561 to 1 | 561/561 (100 %) | 2 diff (99.7 %id) | |||
AI651381 | pooled germ cell tumors | .a | 1068 to 1834 | 767 to 1 | 767/767 (100 %) | 11 diff (98.6 %id) | |||
AI672289 | Kidney | .d-u | 1679 to 2004 | 326 to 1 | 326/326 (100 %) | 0 diff (100 %id) | |||
AI914465 | pooled | .a | 1704 to 2034 | 331 to 1 | 331/331 (100 %) | 0 diff (100 %id) | |||
AI802606 | colon, colonic mucosa from 5 ulcerative colitispatients | .a | 1457 to 1833 | 380 to 4 | 377/380 (99 %) | 0 diff (100 %id) | |||
AI742566 | pooled | .a | 1451 to 2031 | 583 to 1 | 583/583 (100 %) | 3 diff (99.5 %id) | |||
AI819304 | pooled | .a | 1619 to 2031 | 415 to 1 | 415/415 (100 %) | 16 diff (96.2 %id) | |||
AI769490 | Kidney | .a | 1339 to 1834 | 525 to 29 | AAA | 497/497 (100 %) | 10 diff (98.0 %id) | ||
AI770002 | Kidney | .d-u | 1646 to 2004 | 359 to 1 | 359/359 (100 %) | 1 diff (99.8 %id) | |||
AI860170 | lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) | .a | 1036 to 1828 | 799 to 4 | 796/799 (99 %) | 0 diff (100 %id) | |||
AI955687 | adenocarcinoma, Pancreas | .a | 1026 to 1827 | 802 to 1 | 802/802 (100 %) | 21 diff (97.4 %id) | |||
BI497461 | cochlea, ear | .d-u | 1754 to 2004 | 8 to 258 | 251/262 (95 %) | 3 diff (98.9 %id) | |||
AI953406 | normal epithelium, ovary | .d-u | 709 to 1114 | 405 to 1 | 405/405 (100 %) | 1 diff (99.8 %id) | |||
AW071469 | connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma | .a | 1164 to 1633 | 468 to 1 | 468/468 (100 %) | 14 diff (97.1 %id) | |||
AW148428 | Kidney, renal cell tumor | .a | 1544 to 1828 | 293 to 8 | 286/293 (97 %) | 0 diff (100 %id) | |||
AW130184 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .a | 1150 to 1828 | 681 to 6 | 676/681 (99 %) | 0 diff (100 %id) | |||
AW130181 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .a | 1116 to 1828 | 714 to 6 | 709/714 (99 %) | 0 diff (100 %id) | |||
AW235068 | Kidney | .a | 1547 to 1815 | 270 to 1 | 270/270 (100 %) | 2 diff (99.3 %id) | |||
AW243031 | Kidney | .a | 1377 to 1840 | 464 to 1 | 464/464 (100 %) | 2 diff (99.6 %id) | |||
AW136084 | .a | 4540 to 5000 | 478 to 18 | AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 461/461 (100 %) | 1 diff (99.8 %id) | ||
AW294132 | .b | 1277 to 1810 | 551 to 18 | tiling clone, AAA | 534/534 (100 %) | 1 diff (99.9 %id) | |||
AW296874 | .d-u | 1054 to 1416 | 380 to 18 | AAA | Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) | 363/363 (100 %) | 1 diff (99.8 %id) | ||
AW296723 | .a | 781 to 1199 | 432 to 14 | AAA | 419/419 (100 %) | 1 diff (99.8 %id) | |||
AW302165 | Kidney | .a | 1385 to 1840 | 457 to 2 | 456/457 (99 %) | 0 diff (100 %id) | |||
AW467145 | 2 pooled tumors (clear cell type), Kidney | .d-u | 1513 to 2004 | 500 to 9 | 492/500 (98 %) | 0 diff (100 %id) | |||
AW613958 | Kidney | .d-u | 1568 to 2003 | 446 to 11 | AAA | 436/436 (100 %) | 0 diff (100 %id) | ||
AW615349 | 2 pooled high-grade transitional celltumors, genitourinary tract | .a | 1569 to 1834 | 283 to 17 | AAA | 267/267 (100 %) | 1 diff (99.7 %id) | ||
AW630305 | 2 pooled high-grade transitional celltumors, genitourinary tract | .a | 1028 to 1468 | 1 to 441 | 441/441 (100 %) | 0 diff (100 %id) | |||
AW661963 | 2 pooled high-grade transitional celltumors, genitourinary tract | .d-u | 1568 to 2003 | 437 to 1 | 437/437 (100 %) | 3 diff (99.4 %id) | |||
AW661972 | 2 pooled high-grade transitional celltumors, genitourinary tract | .d-u | 1569 to 2003 | 436 to 1 | 436/436 (100 %) | 3 diff (99.4 %id) | |||
BE298215 | muscle, rhabdomyosarcoma | .a | 199 to 732 | 169 to 714 | 529/714 (74 %) | 32 diff (95.6 %id) | |||
BF513360 | .d-u | 1540 to 2003 | 481 to 18 | AAA | 464/464 (100 %) | 1 diff (99.8 %id) | |||
CF138827 | lymph | .a | 5067 to 5479 | 1 to 413 | 413/413 (100 %) | 4 diff (99.1 %id) | |||
CF139868 | CNCAP(3)T-225 cell line, Prostate | .a | 579 to 1095 | 1 to 517 | 517/517 (100 %) | 5 diff (99.1 %id) | |||
BE463854 | pooled germ cell tumors | .a | 1140 to 1834 | 697 to 1 | 697/697 (100 %) | 34 diff (95.2 %id) | |||
BE467002 | carcinoid, lung | .a | 4495 to 4999 | 505 to 1 | 505/505 (100 %) | 1 diff (99.9 %id) | |||
BE550144 | carcinoid, lung | .a | 1487 to 2030 | 544 to 1 | 544/546 (99 %) | 0 diff (100 %id) | |||
BF431654 | Kidney | .a | 1475 to 1827 | 366 to 14 | AAA | 353/353 (100 %) | 0 diff (100 %id) | ||
BE646362 | B-cell, chronic lymphotic leukemia | .a | 1380 to 1828 | 452 to 3 | 450/452 (99 %) | 0 diff (100 %id) | |||
BF063561 | colon, colon tumor, RER+ | .a | 1339 to 1833 | 495 to 1 | 495/495 (100 %) | 0 diff (100 %id) | |||
BF110681 | carcinoid, lung | .a | 1612 to 2032 | 423 to 3 | 421/423 (99 %) | 0 diff (100 %id) | |||
BE567783 | bladder, carcinoma, cell line | .d-u | 339 to 1025 | 1 to 689 | 689/769 (89 %) | 43 diff (94.5 %id) | |||
BE567435 | bladder, carcinoma, cell line | .d-u | 339 to 942 | 1 to 605 | 605/781 (77 %) | 23 diff (97.1 %id) | |||
BE568515 | bladder, carcinoma, cell line | .a | 583 to 1165 | 1 to 581 | 581/589 (98 %) | 12 diff (98.0 %id) | |||
BF433190 | carcinoid, lung | .d-u | 464 to 999 | 1 to 535 | Submitted on the opposite strand | 535/535 (100 %) | 4 diff (99.3 %id) | ||
BC016864 | Colon, adenocarcinoma | .d-u | 959 to 2003 | 1 to 1045 | exact | tiling clone, available from MGC, AAA | 1045/1045 (100 %) | 1 diff (100.0 %id) | |
BF038718 | adenocarcinoma, ovary | .d-u | 201 to 868 | 1 to 661 | 661/937 (70 %) | 19 diff (98.0 %id) | |||
BE874778 | large cell carcinoma, undifferentiated, lung | .a | 1355 to 1938 | 1 to 588 | 588/868 (67 %) | 35 diff (96.0 %id) | |||
BE881297 | large cell carcinoma, undifferentiated, lung | .a | 4559 to 5332 | 1 to 767 | 767/803 (95 %) | 31 diff (96.2 %id) | |||
BE882785 | leiomyosarcoma, uterus | .d-u | 1785 to 1997 | 1 to 215 | 215/216 (99 %) | 6 diff (97.3 %id) | |||
BE886990 | leiomyosarcoma, uterus | .a | 115 to 851 | 1 to 735 | 735/736 (99 %) | 6 diff (99.2 %id) | |||
BE887149 | leiomyosarcoma, uterus | .a | 3419 to 4121 | 1 to 702 | tiling clone, AAA | 702/933 (75 %) | 18 diff (98.1 %id) | ||
BE888815 | leiomyosarcoma, uterus | .a | 4570 to 5326 | 1 to 749 | tiling clone, | 749/913 (82 %) | 21 diff (97.7 %id) | ||
BC007036 | Bladder, carcinoma | .a | 633 to 1826 | 1 to 1194 | available from MGC, AAA | 1194/1194 (100 %) | 2 diff (99.9 %id) | ||
BF029388 | bladder, carcinoma, cell line | .a | 648 to 1144 | 1 to 499 | available from MGC, | 499/908 (54 %) | 16 diff (98.3 %id) | ||
BF570973 | melanotic melanoma, high MDR, skin | .a | 482 to 974 | 1 to 503 | 503/885 (56 %) | 17 diff (98.1 %id) | |||
BF572951 | melanotic melanoma, high MDR, skin | .a | 1474 to 2171 | 1 to 709 | 709/859 (82 %) | 49 diff (94.3 %id) | |||
BF671244 | muscle (skeletal) | .d-u | 917 to 1497 | 1 to 586 | 586/589 (99 %) | 21 diff (96.5 %id) | |||
BF971311 | adrenal cortex carcinoma, cell line, adrenal gland | .a | 611 to 1398 | 1 to 784 | 784/791 (99 %) | 22 diff (97.3 %id) | |||
BF971249 | adrenal cortex carcinoma, cell line, adrenal gland | .a | 609 to 1231 | 1 to 624 | 624/624 (100 %) | 1 diff (99.9 %id) | |||
BG024079 | duodenal adenocarcinoma, cell line, small intestine | .a | 39 to 626 | 1 to 603 | 601/1066 (56 %) | 29 diff (97.3 %id) | |||
BG117302 | adenocarcinoma, cell line, Liver | .a | 348 to 1087 | 1 to 736 | 736/1001 (73 %) | 16 diff (98.5 %id) | |||
BG164109 | hypernephroma, cell line, Kidney | .a | 53 to 757 | 1 to 719 | 714/1091 (65 %) | 35 diff (96.8 %id) | |||
BG250903 | adenocarcinoma, cell line, Liver | .a | 618 to 1283 | 11 to 679 | 669/971 (68 %) | 11 diff (98.9 %id) | |||
BG286261 | bladder, transitional cell papilloma, cell line | .a | 1501 to 1827 | 1 to 327 | AAA | 327/327 (100 %) | 0 diff (100 %id) | ||
BG283190 | adenocarcinoma, cell line, Prostate | .a | 628 to 1072 | 1 to 466 | 435/467 (93 %) | 18 diff (96.2 %id) | |||
BG283263 | adenocarcinoma, cell line, Prostate | .a | 628 to 1140 | 1 to 519 | 519/733 (70 %) | 16 diff (97.9 %id) | |||
BG285194 | adenocarcinoma, cell line, Prostate | .d-u | 1438 to 1998 | 1 to 558 | P2R K18I W32G P33R L34F ... | AAA | 558/558 (100 %) | 11 diff (98.1 %id) | |
BG622287 | placenta | .a | 4594 to 5291 | 1 to 699 | 699/699 (100 %) | 9 diff (98.8 %id) | |||
BG715379 | brain, hypothalamus | .a | 45 to 866 | 9 to 828 | 820/830 (98 %) | 23 diff (97.3 %id) | |||
BC042545 | testis | .a | 5949 to 8669 | 1 to 2721 | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 2721/2721 (100 %) | 1 diff (100.0 %id) | |
BG719137 | testis | .a | 5944 to 6550 | 1 to 608 | available from MGC, | 608/608 (100 %) | 7 diff (98.9 %id) | ||
BI333411 | cervical carcinoma cell line, cervix | .a | 53 to 894 | 1 to 857 | I21X W99R I155H N156* | 857/858 (99 %) | 13 diff (98.5 %id) | ||
BI517634 | pooled colon, kidney, stomach | .a | 21 to 733 | 1 to 722 | 722/1120 (64 %) | 20 diff (98.3 %id) | |||
BI521272 | pooled pancreas and spleen | .a | 66 to 768 | 1 to 733 | 707/812 (87 %) | 52 diff (93.6 %id) | |||
BI522098 | pooled pancreas and spleen | .a | 1127 to 1783 | 663 to 1 | 663/664 (99 %) | 9 diff (98.7 %id) | |||
BI839021 | pooled pancreas and spleen | .a | 56 to 763 | 18 to 757 | 740/757 (97 %) | 23 diff (97.0 %id) | |||
BI917076 | brain | .c | 1 to 522 | 1 to 522 | exact | tiling clone, | 522/527 (99 %) | 1 diff (99.9 %id) | |
BI464956 | testis | .a | 21 to 691 | 1 to 673 | 673/761 (88 %) | 28 diff (96.4 %id) | |||
BI457862 | brain, hypothalamus | .a | 15 to 574 | 1 to 560 | 560/562 (99 %) | 4 diff (99.3 %id) | |||
BI603104 | brain, hypothalamus | .a | 62 to 909 | 1 to 855 | I21M V22C W23G R24G F25L ... | 855/857 (99 %) | 49 diff (94.3 %id) | ||
BM471168 | leiomyosarcoma, uterus | .a | 769 to 1545 | 21 to 809 | 789/1142 (69 %) | 39 diff (96.6 %id) | |||
BM464381 | leiomyosarcoma, uterus | .a | 1 to 769 | 31 to 803 | tiling clone, | 773/1243 (62 %) | 19 diff (98.5 %id) | ||
BM542332 | melanotic melanoma, skin | .a | 6554 to 7343 | 1 to 798 | AAA | 798/975 (81 %) | 18 diff (98.2 %id) | ||
BM905731 | leiomyosarcoma, uterus | .a | 4650 to 5455 | 1 to 815 | 815/1068 (76 %) | 20 diff (98.2 %id) | |||
BM922244 | pooled brain, lung, testis | .a | 54 to 768 | 18 to 735 | 718/987 (72 %) | 10 diff (99.0 %id) | |||
BQ000852 | lung, Metastatic Chondrosarcoma | .d-u | 663 to 1416 | 1 to 754 | Submitted on the opposite strand | 754/754 (100 %) | 6 diff (99.3 %id) | ||
BQ004567 | Chondrosarcoma, Left Pelvis | .a | 1147 to 1827 | 698 to 19 | AAA | 680/680 (100 %) | 1 diff (99.9 %id) | ||
BQ003477 | Chondrosarcoma, Left Pelvis | .a | 1171 to 1827 | 673 to 19 | AAA | 655/655 (100 %) | 6 diff (99.1 %id) | ||
BQ549080 | insulinoma, Pancreas | .d-u | 821 to 1251 | 1 to 432 | 432/432 (100 %) | 6 diff (98.7 %id) | |||
BQ549567 | insulinoma, Pancreas | .d-u | 1401 to 2003 | 619 to 17 | exact | AAA | 603/603 (100 %) | 1 diff (99.9 %id) | |
BU072943 | Pancreas, Purified pancreatic islet | .d-u | 1357 to 1956 | 1 to 601 | W45C P46S | 601/601 (100 %) | 6 diff (99.1 %id) | ||
BQ229367 | melanotic melanoma, skin | .d-u | 437 to 960 | 10 to 539 | 530/1317 (40 %) | 23 diff (98.3 %id) | |||
BQ433929 | embryonal carcinoma, cell line, testis | .d-u | 486 to 1354 | 1 to 879 | 879/880 (99 %) | 16 diff (98.2 %id) | |||
BQ429759 | bone marrow, from acute myelogenous leukemia | .d-u | 351 to 999 | 1 to 655 | 655/814 (80 %) | 19 diff (97.7 %id) | |||
BU165456 | eye, retinoblastoma | .a | 1685 to 1834 | 28 to 177 | AAA | 150/177 (84 %) | 6 diff (96.7 %id) | ||
BU177540 | melanotic melanoma, skin | .a | 188 to 1099 | 1 to 913 | 913/913 (100 %) | 7 diff (99.3 %id) | |||
BU146346 | dorsal root ganglia | .a | 51 to 894 | 1 to 847 | K181Q R183P R184K Q185T P186A ... | 847/925 (91 %) | 10 diff (99.0 %id) | ||
BQ925929 | sciatic nerve | .a | 792 to 1619 | 1 to 840 | 840/978 (85 %) | 25 diff (97.5 %id) | |||
BQ956143 | sciatic nerve | .e-u | 1 to 882 | 1 to 887 | exact | tiling clone, | 887/889 (99 %) | 25 diff (97.2 %id) | |
BQ918422 | sciatic nerve | .a | 40 to 892 | 1 to 859 | K181Q R183P E188R P189A R191A ... | 859/930 (92 %) | 13 diff (98.7 %id) | ||
BQ641787 | eye, normal pigmented retinal epithelium | .a | 349 to 1260 | 2 to 919 | 918/928 (98 %) | 20 diff (97.9 %id) | |||
BQ654010 | hepatocellular carcinoma, cell line, Liver | .a | 75 to 959 | 13 to 903 | E127Q V145G E146K I155L S163T ... | 891/942 (94 %) | 37 diff (96.1 %id) | ||
BU537741 | mixed (pool of 40 RNAs) | .a | 1469 to 1824 | 1 to 358 | 358/392 (91 %) | 4 diff (99.0 %id) | |||
BU538226 | adenocarcinoma, cell line, breast | .a | 62 to 770 | 1 to 710 | 710/964 (73 %) | 10 diff (99.0 %id) | |||
CA867934 | Pancreas, Purified pancreatic islet | .d-u | -8 to 391 | 1 to 400 | tiling clone, | 400/400 (100 %) | 2 diff (99.5 %id) | ||
CA943662 | Pancreas, Purified pancreatic islet | .d-u | 623 to 1109 | 483 to 1 | 483/483 (100 %) | 3 diff (99.4 %id) | |||
BU934056 | mixed (pool of 40 RNAs) | .d-u | 1398 to 2001 | 1 to 604 | K18I | 604/799 (75 %) | 8 diff (99.0 %id) | ||
CX873454 | embryonic stem | .a | 525 to 1390 | 1 to 866 | 866/866 (100 %) | 0 diff (100 %id) | |||
CB995846 | placenta, pre-eclamptic placenta | .a | 1535 to 1834 | 27 to 326 | AAA | 300/326 (92 %) | 6 diff (98.2 %id) | ||
CB956871 | Pooled-Glandular | .a | 5425 to 6126 | 1 to 710 | 710/760 (93 %) | 17 diff (97.8 %id) | |||
CF128723 | Chondrosarcoma Lung Metastasis cell lines, lung | .a | 1314 to 1838 | 1 to 524 | AAA | 524/524 (100 %) | 2 diff (99.7 %id) | ||
CF786096 | mixed | .a | 5468 to 6009 | 21 to 558 | 538/761 (70 %) | 16 diff (97.9 %id) | |||
CK001432 | brain/CNS, Bulk tissue from Human Spinal cord | .d-u | 483 to 1140 | 1 to 654 | 654/669 (97 %) | 12 diff (98.3 %id) | |||
CK003858 | brain/CNS, Human Brain - Cerebellar Cortex | .d-u | 577 to 1268 | 1 to 688 | 688/689 (99 %) | 9 diff (98.7 %id) | |||
TI_45236509 | .a | 16 to 733 | 57 to 783 | 727/1181 (61 %) | 15 diff (98.8 %id) | ||||
TI_57165968 | .a | 56 to 763 | 18 to 757 | 740/757 (97 %) | 23 diff (97.0 %id) | ||||
TI_57242362 | .c | 1 to 522 | 33 to 554 | exact | 522/559 (93 %) | 7 diff (98.8 %id) | |||
TI_45216524 | .a | 64 to 909 | 124 to 976 | I21M V22C W23G R24G F25L ... | 853/978 (87 %) | 52 diff (94.7 %id) | |||
BP275251 | Kidney | .a | 24 to 604 | 1 to 581 | 581/581 (100 %) | 1 diff (99.9 %id) | |||
NM_020673.2 | .a | 20 to 8669 | 1 to 8650 | RefSeq, AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 8650/8650 (100 %) | 0 diff (100 %id) | ||
DA722225 | .a | 4845 to 5405 | 2 to 562 | capped | 561/561 (100 %) | 2 diff (99.7 %id) | |||
DA775827 | brain | .a | 3719 to 4282 | 2 to 565 | capped | 564/564 (100 %) | 2 diff (99.7 %id) | ||
DB325974 | brain | .a | 7214 to 7776 | 564 to 1 | 564/564 (100 %) | 2 diff (99.7 %id) | |||
DA776840 | brain | .a | 5294 to 5874 | 2 to 582 | capped | 581/581 (100 %) | 0 diff (100 %id) | ||
DA780343 | brain | .a | 5500 to 5747 | 2 to 251 | capped | 250/250 (100 %) | 2 diff (99.2 %id) | ||
DB326206 | brain | .a | 7230 to 7776 | 547 to 1 | 547/547 (100 %) | 1 diff (99.9 %id) | |||
DA785684 | brain | .a | 5702 to 6081 | 2 to 381 | capped | 380/380 (100 %) | 2 diff (99.5 %id) | ||
DA797532 | brain | .a | 4154 to 4714 | 2 to 562 | tiling clone, capped | 561/561 (100 %) | 2 diff (99.7 %id) | ||
CK429657 | eye, lacrimal gland | .a | 6586 to 7226 | 1 to 641 | 641/641 (100 %) | 0 diff (100 %id) | |||
DA837220 | placenta | .d-u | 1 to 543 | 2 to 545 | capped | 544/544 (100 %) | 1 diff (99.9 %id) | ||
DB328275 | placenta | .d-u | 1454 to 2003 | 552 to 1 | exact | 552/552 (100 %) | 2 diff (99.7 %id) | ||
CR995120 | T-Lymphocytes | .a | 63 to 577 | 1 to 515 | 515/516 (99 %) | 1 diff (99.9 %id) | |||
CR981142 | T-Lymphocytes | .a | 44 to 374 | 1 to 330 | 330/330 (100 %) | 1 diff (99.7 %id) | |||
BM741391 | Ascites, stomach | .a | 406 to 1062 | 1 to 657 | 657/657 (100 %) | 0 diff (100 %id) | |||
BM747961 | Ascites, stomach | .a | 406 to 910 | 1 to 505 | 505/505 (100 %) | 0 diff (100 %id) | |||
BM745549 | Ascites, stomach | .a | 406 to 911 | 1 to 507 | 507/507 (100 %) | 1 diff (99.9 %id) | |||
BM767269 | Ascites, stomach | .a | 406 to 1076 | 1 to 671 | 671/671 (100 %) | 0 diff (100 %id) | |||
BM771110 | Ascites, stomach | .a | 406 to 980 | 1 to 576 | 576/576 (100 %) | 1 diff (99.9 %id) | |||
BM763371 | myeloma | .a | 406 to 1045 | 1 to 641 | 641/641 (100 %) | 2 diff (99.7 %id) | |||
BM822665 | stomach | .a | 520 to 966 | 1 to 447 | 447/447 (100 %) | 3 diff (99.4 %id) | |||
TI_1948099280 | .a | 283 to 784 | 127 to 628 | 502/532 (94 %) | 8 diff (98.5 %id) | ||||
DN991711 | brain, whole brain | .a | 30 to 530 | 1 to 501 | 501/501 (100 %) | 5 diff (99.1 %id) | |||
DB017463 | esophageal, tumor tissue | .a | 6407 to 6975 | 2 to 571 | capped | 570/570 (100 %) | 1 diff (99.9 %id) | ||
TI_149272910 | .a | 1268 to 1833 | 699 to 136 | AAA | 564/981 (57 %) | 17 diff (98.3 %id) | |||
TI_149283435 | .a | 1336 to 1827 | 576 to 85 | AAA | 492/698 (70 %) | 3 diff (99.6 %id) | |||
TI_149287428 | .a | 1330 to 2298 | 1016 to 63 | AAA | 954/1160 (82 %) | 30 diff (97.5 %id) | |||
TI_149291308 | .a | 1104 to 2031 | 996 to 82 | AAA | 915/951 (96 %) | 24 diff (97.5 %id) | |||
TI_149291340 | .d-u | 576 to 1291 | 824 to 109 | tiling clone, AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 716/905 (79 %) | 4 diff (99.6 %id) | ||
TI_149293649 | .a | 1050 to 1827 | 854 to 87 | AAA | 768/961 (79 %) | 14 diff (98.6 %id) | |||
TI_149303640 | .a | 965 to 1833 | 933 to 82 | AAA | 852/937 (90 %) | 45 diff (95.2 %id) | |||
TI_149313581 | .a | 1254 to 2031 | 868 to 104 | AAA | 765/926 (82 %) | 19 diff (98.0 %id) | |||
TI_154168976 | .a | 5074 to 5600 | 77 to 603 | tiling clone, | 527/527 (100 %) | 0 diff (100 %id) | |||
TI_154170236 | .a | 585 to 1115 | 79 to 609 | 531/531 (100 %) | 1 diff (99.9 %id) | ||||
TI_154194877 | .a | 1314 to 1838 | 41 to 564 | AAA | 524/524 (100 %) | 2 diff (99.7 %id) | |||
TI_159718884 | .a | 1356 to 2289 | 1034 to 115 | AAA | 920/1030 (89 %) | 31 diff (97.0 %id) | |||
DB168425 | kidney, tumor tissue | .a | 4499 to 5073 | 2 to 576 | capped | 575/575 (100 %) | 0 diff (100 %id) | ||
DB171417 | kidney, tumor tissue | .a | 6217 to 6787 | 2 to 572 | capped | 571/571 (100 %) | 1 diff (99.9 %id) | ||
DB221554 | trachea | .a | 5034 to 5579 | 2 to 547 | capped | 546/546 (100 %) | 0 diff (100 %id) | ||
BQ024280 | placenta | .a | 2087 to 2554 | 486 to 19 | AAA | 468/468 (100 %) | 0 diff (100 %id) | ||
BQ013056 | placenta | .a | 1410 to 1827 | 437 to 19 | AAA | 419/419 (100 %) | 1 diff (99.8 %id) | ||
BU675404 | lung, Primary Lung Epithelial Cells | .a | 1375 to 1833 | 476 to 19 | AAA | 458/458 (100 %) | 5 diff (99.0 %id) | ||
BM984069 | lung, Primary Lung Epithelial Cells | .a | 1336 to 1827 | 510 to 19 | AAA | 492/494 (99 %) | 3 diff (99.4 %id) | ||
BM972748 | lung | .a | 1549 to 2298 | 766 to 19 | tiling clone, AAA | 748/748 (100 %) | 3 diff (99.6 %id) | ||
BM973886 | lung | .d-u | 692 to 1291 | 618 to 19 | AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 600/600 (100 %) | 0 diff (100 %id) | |
BM973944 | lung | .a | 1295 to 2031 | 756 to 19 | AAA | 738/738 (100 %) | 2 diff (99.8 %id) | ||
BM975191 | lung | .a | 1108 to 1827 | 734 to 19 | AAA | 716/716 (100 %) | 7 diff (99.1 %id) | ||
CB851071 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 1089 to 1833 | 762 to 19 | AAA | 744/744 (100 %) | 5 diff (99.4 %id) | ||
CB305462 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 1415 to 2031 | 635 to 19 | AAA | 617/617 (100 %) | 3 diff (99.6 %id) | ||
CB241988 | Human Lung Epithelial cells, lung | .d-u | 1292 to 2003 | 728 to 17 | K18I | AAA | 712/713 (99 %) | 4 diff (99.5 %id) | |
CB250689 | Human Lung Epithelial cells, lung | .a | 1379 to 1838 | 478 to 19 | AAA | 460/469 (98 %) | 0 diff (100 %id) | ||
BM713620 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1352 to 1706 | 1 to 357 | 357/357 (100 %) | 2 diff (99.5 %id) | |||
BM718578 | eye, fetal eye | .d-u | 1664 to 2001 | 1 to 338 | AAA | 338/338 (100 %) | 0 diff (100 %id) | ||
CA414187 | Knee, Osteoarthritic Cartilage | .d-u | 1402 to 2001 | 615 to 16 | K18I | AAA | 600/600 (100 %) | 4 diff (99.4 %id) | |
CA431573 | cell lines, Enchondroma | .a | 1125 to 1827 | 716 to 19 | AAA | 698/698 (100 %) | 9 diff (98.8 %id) | ||
CA428943 | Cell Line, Chondrosarcoma | .d-u | 1754 to 2003 | 266 to 17 | AAA | 250/252 (99 %) | 2 diff (99.3 %id) | ||
CA429001 | Cell Line, Chondrosarcoma | .d-u | 1402 to 2001 | 615 to 16 | K18I | AAA | 600/600 (100 %) | 8 diff (98.7 %id) | |
CA429027 | Cell Line, Chondrosarcoma | .d-u | 462 to 1110 | 658 to 14 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 645/645 (100 %) | 3 diff (99.6 %id) | |
BU629842 | cell lines, Chondrosarcoma | .d-u | 1282 to 2003 | 740 to 19 | K18I | AAA | 722/722 (100 %) | 7 diff (99.1 %id) | |
BU633803 | cell lines, Chondrosarcoma | .a | 1072 to 1833 | 779 to 18 | AAA | 762/762 (100 %) | 0 diff (100 %id) | ||
CA748617 | Alveolar Macrophage, lung | .a | 1227 to 1833 | 625 to 19 | AAA | 607/607 (100 %) | 1 diff (99.9 %id) | ||
U46388 | liver cell line, pancreatic cancer | .a | 6394 to 6758 | 13 to 380 | 368/383 (96 %) | 7 diff (98.2 %id) | |||
BP380488 | .a | 37 to 662 | 1 to 624 | 624/888 (70 %) | 8 diff (99.1 %id) | ||||
BP872639 | embryonal kidney | .d-u | 1401 to 2003 | 619 to 17 | Suspected internal deletion, this clone was ignored | 603/603 (100 %) | 1 diff (99.9 %id) | ||
AI138768 | .d-u | 1401 to 2003 | 619 to 17 | AAA | 603/603 (100 %) | 1 diff (99.9 %id) | |||
BQ945982 | leiomyosarcoma, uterus | .d-u | 1357 to 1956 | 1 to 601 | Suspected internal deletion, this clone was ignored | 601/601 (100 %) | 6 diff (99.1 %id) | ||
BM838139 | Ascites, stomach | .d-u | 1357 to 1956 | 1 to 601 | This clone was ignored | 601/601 (100 %) | 6 diff (99.1 %id) | ||
DA929637 | small intestine | .d-u | 437 to 960 | 10 to 539 | capped | 530/1317 (40 %) | 23 diff (98.3 %id) | ||
DB332263 | small intestine | .d-u | 437 to 960 | 10 to 539 | 530/1317 (40 %) | 23 diff (98.3 %id) | |||
DB222432 | trachea | .d-u | 486 to 1354 | 1 to 879 | capped | This clone was ignored | 879/880 (99 %) | 16 diff (98.2 %id) | |
DB349480 | trachea | .d-u | 486 to 1354 | 1 to 879 | This clone was ignored | 879/880 (99 %) | 16 diff (98.2 %id) | ||
BQ429759 | bone marrow, from acute myelogenous leukemia | .d-u | 351 to 999 | 1 to 655 | 655/814 (80 %) | 19 diff (97.7 %id) | |||
BQ429759 | bone marrow, from acute myelogenous leukemia | .d-u | 351 to 999 | 1 to 655 | 655/814 (80 %) | 19 diff (97.7 %id) | |||
BU165456 | eye, retinoblastoma | .a | 1685 to 1834 | 28 to 177 | AAA | 150/177 (84 %) | 6 diff (96.7 %id) | ||
BU165456 | eye, retinoblastoma | .a | 1685 to 1834 | 28 to 177 | AAA | 150/177 (84 %) | 6 diff (96.7 %id) | ||
BU177540 | melanotic melanoma, skin | .a | 188 to 1099 | 1 to 913 | 913/913 (100 %) | 7 diff (99.3 %id) | |||
BU177540 | melanotic melanoma, skin | .a | 188 to 1099 | 1 to 913 | 913/913 (100 %) | 7 diff (99.3 %id) | |||
BU146346 | dorsal root ganglia | .a | 51 to 894 | 1 to 847 | K181Q R183P R184K Q185T P186A ... | 847/925 (91 %) | 10 diff (99.0 %id) | ||
BQ925929 | sciatic nerve | .a | 792 to 1619 | 1 to 840 | 840/978 (85 %) | 25 diff (97.5 %id) | |||
BQ956143 | sciatic nerve | .e-u | 1 to 882 | 1 to 887 | exact | tiling clone, | 887/889 (99 %) | 25 diff (97.2 %id) | |
BQ918422 | sciatic nerve | .a | 40 to 892 | 1 to 859 | K181Q R183P E188R P189A R191A ... | 859/930 (92 %) | 13 diff (98.7 %id) | ||
BQ641787 | eye, normal pigmented retinal epithelium | .a | 349 to 1260 | 2 to 919 | 918/928 (98 %) | 20 diff (97.9 %id) | |||
BQ641787 | eye, normal pigmented retinal epithelium | .a | 349 to 1260 | 2 to 919 | 918/928 (98 %) | 20 diff (97.9 %id) | |||
BQ654010 | hepatocellular carcinoma, cell line, Liver | .a | 75 to 959 | 13 to 903 | E127Q V145G E146K I155L S163T ... | 891/942 (94 %) | 37 diff (96.1 %id) | ||
BQ654010 | hepatocellular carcinoma, cell line, Liver | .a | 75 to 959 | 13 to 903 | E127Q V145G E146K I155L S163T ... | 891/942 (94 %) | 37 diff (96.1 %id) | ||
BU537741 | mixed (pool of 40 RNAs) | .a | 1469 to 1824 | 1 to 358 | 358/392 (91 %) | 4 diff (99.0 %id) | |||
BU538226 | adenocarcinoma, cell line, breast | .a | 62 to 770 | 1 to 710 | 710/964 (73 %) | 10 diff (99.0 %id) | |||
BU538226 | adenocarcinoma, cell line, breast | .a | 62 to 770 | 1 to 710 | 710/964 (73 %) | 10 diff (99.0 %id) | |||
CA867934 | Pancreas, Purified pancreatic islet | .d-u | -8 to 391 | 1 to 400 | tiling clone, | 400/400 (100 %) | 2 diff (99.5 %id) | ||
CA867934 | Pancreas, Purified pancreatic islet | .d-u | -8 to 391 | 1 to 400 | tiling clone, | 400/400 (100 %) | 2 diff (99.5 %id) | ||
CA943662 | Pancreas, Purified pancreatic islet | .d-u | 623 to 1109 | 483 to 1 | 483/483 (100 %) | 3 diff (99.4 %id) | |||
CA943662 | Pancreas, Purified pancreatic islet | .d-u | 623 to 1109 | 483 to 1 | 483/483 (100 %) | 3 diff (99.4 %id) | |||
BU934056 | mixed (pool of 40 RNAs) | .d-u | 1398 to 2001 | 1 to 604 | K18I | 604/799 (75 %) | 8 diff (99.0 %id) | ||
CX873454 | embryonic stem | .a | 525 to 1390 | 1 to 866 | 866/866 (100 %) | 0 diff (100 %id) | |||
CB995846 | placenta, pre-eclamptic placenta | .a | 1535 to 1834 | 27 to 326 | AAA | 300/326 (92 %) | 6 diff (98.2 %id) | ||
CB995846 | placenta, pre-eclamptic placenta | .a | 1535 to 1834 | 27 to 326 | AAA | 300/326 (92 %) | 6 diff (98.2 %id) | ||
CB956871 | Pooled-Glandular | .a | 5425 to 6126 | 1 to 710 | 710/760 (93 %) | 17 diff (97.8 %id) | |||
CF128723 | Chondrosarcoma Lung Metastasis cell lines, lung | .a | 1314 to 1838 | 1 to 524 | AAA | 524/524 (100 %) | 2 diff (99.7 %id) | ||
CF128723 | Chondrosarcoma Lung Metastasis cell lines, lung | .a | 1314 to 1838 | 1 to 524 | AAA | 524/524 (100 %) | 2 diff (99.7 %id) | ||
CF786096 | mixed | .a | 5468 to 6009 | 21 to 558 | 538/761 (70 %) | 16 diff (97.9 %id) | |||
CK001432 | brain/CNS, Bulk tissue from Human Spinal cord | .d-u | 483 to 1140 | 1 to 654 | 654/669 (97 %) | 12 diff (98.3 %id) | |||
CK001432 | brain/CNS, Bulk tissue from Human Spinal cord | .d-u | 483 to 1140 | 1 to 654 | 654/669 (97 %) | 12 diff (98.3 %id) | |||
CK003858 | brain/CNS, Human Brain - Cerebellar Cortex | .d-u | 577 to 1268 | 1 to 688 | 688/689 (99 %) | 9 diff (98.7 %id) | |||
CK003858 | brain/CNS, Human Brain - Cerebellar Cortex | .d-u | 577 to 1268 | 1 to 688 | 688/689 (99 %) | 9 diff (98.7 %id) | |||
TI_45236509 | .a | 16 to 733 | 57 to 783 | 727/1181 (61 %) | 15 diff (98.8 %id) | ||||
TI_57165968 | .a | 56 to 763 | 18 to 757 | 740/757 (97 %) | 23 diff (97.0 %id) | ||||
TI_57242362 | .c | 1 to 522 | 33 to 554 | exact | 522/559 (93 %) | 7 diff (98.8 %id) | |||
TI_45216524 | .a | 64 to 909 | 124 to 976 | I21M V22C W23G R24G F25L ... | 853/978 (87 %) | 52 diff (94.7 %id) | |||
BP275251 | Kidney | .a | 24 to 604 | 1 to 581 | 581/581 (100 %) | 1 diff (99.9 %id) | |||
NM_020673.2 | .a | 20 to 8669 | 1 to 8650 | RefSeq, AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 8650/8650 (100 %) | 0 diff (100 %id) | ||
DA722225 | .a | 4845 to 5405 | 2 to 562 | capped | 561/561 (100 %) | 2 diff (99.7 %id) | |||
DA775827 | brain | .a | 3719 to 4282 | 2 to 565 | capped | 564/564 (100 %) | 2 diff (99.7 %id) | ||
DB325974 | brain | .a | 7214 to 7776 | 564 to 1 | 564/564 (100 %) | 2 diff (99.7 %id) | |||
DA776840 | brain | .a | 5294 to 5874 | 2 to 582 | capped | 581/581 (100 %) | 0 diff (100 %id) | ||
DA780343 | brain | .a | 5500 to 5747 | 2 to 251 | capped | 250/250 (100 %) | 2 diff (99.2 %id) | ||
DB326206 | brain | .a | 7230 to 7776 | 547 to 1 | 547/547 (100 %) | 1 diff (99.9 %id) | |||
DA785684 | brain | .a | 5702 to 6081 | 2 to 381 | capped | 380/380 (100 %) | 2 diff (99.5 %id) | ||
DA797532 | brain | .a | 4154 to 4714 | 2 to 562 | tiling clone, capped | 561/561 (100 %) | 2 diff (99.7 %id) | ||
CK429657 | eye, lacrimal gland | .a | 6586 to 7226 | 1 to 641 | 641/641 (100 %) | 0 diff (100 %id) | |||
CK429657 | eye, lacrimal gland | .a | 6586 to 7226 | 1 to 641 | 641/641 (100 %) | 0 diff (100 %id) | |||
DA837220 | placenta | .d-u | 1 to 543 | 2 to 545 | capped | 544/544 (100 %) | 1 diff (99.9 %id) | ||
DB328275 | placenta | .d-u | 1454 to 2003 | 552 to 1 | exact | 552/552 (100 %) | 2 diff (99.7 %id) | ||
CR995120 | T-Lymphocytes | .a | 63 to 577 | 1 to 515 | 515/516 (99 %) | 1 diff (99.9 %id) | |||
CR981142 | T-Lymphocytes | .a | 44 to 374 | 1 to 330 | 330/330 (100 %) | 1 diff (99.7 %id) | |||
BM741391 | Ascites, stomach | .a | 406 to 1062 | 1 to 657 | 657/657 (100 %) | 0 diff (100 %id) | |||
BM741391 | Ascites, stomach | .a | 406 to 1062 | 1 to 657 | 657/657 (100 %) | 0 diff (100 %id) | |||
BM747961 | Ascites, stomach | .a | 406 to 910 | 1 to 505 | 505/505 (100 %) | 0 diff (100 %id) | |||
BM747961 | Ascites, stomach | .a | 406 to 910 | 1 to 505 | 505/505 (100 %) | 0 diff (100 %id) | |||
BM745549 | Ascites, stomach | .a | 406 to 911 | 1 to 507 | 507/507 (100 %) | 1 diff (99.9 %id) | |||
BM745549 | Ascites, stomach | .a | 406 to 911 | 1 to 507 | 507/507 (100 %) | 1 diff (99.9 %id) | |||
BM767269 | Ascites, stomach | .a | 406 to 1076 | 1 to 671 | 671/671 (100 %) | 0 diff (100 %id) | |||
BM767269 | Ascites, stomach | .a | 406 to 1076 | 1 to 671 | 671/671 (100 %) | 0 diff (100 %id) | |||
BM771110 | Ascites, stomach | .a | 406 to 980 | 1 to 576 | 576/576 (100 %) | 1 diff (99.9 %id) | |||
BM771110 | Ascites, stomach | .a | 406 to 980 | 1 to 576 | 576/576 (100 %) | 1 diff (99.9 %id) | |||
BM763371 | myeloma | .a | 406 to 1045 | 1 to 641 | 641/641 (100 %) | 2 diff (99.7 %id) | |||
BM822665 | stomach | .a | 520 to 966 | 1 to 447 | 447/447 (100 %) | 3 diff (99.4 %id) | |||
TI_1948099280 | .a | 283 to 784 | 127 to 628 | 502/532 (94 %) | 8 diff (98.5 %id) | ||||
DN991711 | brain, whole brain | .a | 30 to 530 | 1 to 501 | 501/501 (100 %) | 5 diff (99.1 %id) | |||
DN991711 | brain, whole brain | .a | 30 to 530 | 1 to 501 | 501/501 (100 %) | 5 diff (99.1 %id) | |||
DB017463 | esophageal, tumor tissue | .a | 6407 to 6975 | 2 to 571 | capped | 570/570 (100 %) | 1 diff (99.9 %id) | ||
TI_149272910 | .a | 1268 to 1833 | 699 to 136 | AAA | 564/981 (57 %) | 17 diff (98.3 %id) | |||
TI_149283435 | .a | 1336 to 1827 | 576 to 85 | AAA | 492/698 (70 %) | 3 diff (99.6 %id) | |||
TI_149287428 | .a | 1330 to 2298 | 1016 to 63 | AAA | 954/1160 (82 %) | 30 diff (97.5 %id) | |||
TI_149291308 | .a | 1104 to 2031 | 996 to 82 | AAA | 915/951 (96 %) | 24 diff (97.5 %id) | |||
TI_149291340 | .d-u | 576 to 1291 | 824 to 109 | tiling clone, AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 716/905 (79 %) | 4 diff (99.6 %id) | ||
TI_149293649 | .a | 1050 to 1827 | 854 to 87 | AAA | 768/961 (79 %) | 14 diff (98.6 %id) | |||
TI_149303640 | .a | 965 to 1833 | 933 to 82 | AAA | 852/937 (90 %) | 45 diff (95.2 %id) | |||
TI_149313581 | .a | 1254 to 2031 | 868 to 104 | AAA | 765/926 (82 %) | 19 diff (98.0 %id) | |||
TI_154168976 | .a | 5074 to 5600 | 77 to 603 | tiling clone, | 527/527 (100 %) | 0 diff (100 %id) | |||
TI_154170236 | .a | 585 to 1115 | 79 to 609 | 531/531 (100 %) | 1 diff (99.9 %id) | ||||
TI_154194877 | .a | 1314 to 1838 | 41 to 564 | AAA | 524/524 (100 %) | 2 diff (99.7 %id) | |||
TI_159718884 | .a | 1356 to 2289 | 1034 to 115 | AAA | 920/1030 (89 %) | 31 diff (97.0 %id) | |||
DB168425 | kidney, tumor tissue | .a | 4499 to 5073 | 2 to 576 | capped | 575/575 (100 %) | 0 diff (100 %id) | ||
DB171417 | kidney, tumor tissue | .a | 6217 to 6787 | 2 to 572 | capped | 571/571 (100 %) | 1 diff (99.9 %id) | ||
DB221554 | trachea | .a | 5034 to 5579 | 2 to 547 | capped | 546/546 (100 %) | 0 diff (100 %id) | ||
BQ024280 | placenta | .a | 2087 to 2554 | 486 to 19 | AAA | 468/468 (100 %) | 0 diff (100 %id) | ||
BQ013056 | placenta | .a | 1410 to 1827 | 437 to 19 | AAA | 419/419 (100 %) | 1 diff (99.8 %id) | ||
BU675404 | lung, Primary Lung Epithelial Cells | .a | 1375 to 1833 | 476 to 19 | AAA | 458/458 (100 %) | 5 diff (99.0 %id) | ||
BU675404 | lung, Primary Lung Epithelial Cells | .a | 1375 to 1833 | 476 to 19 | AAA | 458/458 (100 %) | 5 diff (99.0 %id) | ||
BM984069 | lung, Primary Lung Epithelial Cells | .a | 1336 to 1827 | 510 to 19 | AAA | 492/494 (99 %) | 3 diff (99.4 %id) | ||
BM984069 | lung, Primary Lung Epithelial Cells | .a | 1336 to 1827 | 510 to 19 | AAA | 492/494 (99 %) | 3 diff (99.4 %id) | ||
BM972748 | lung | .a | 1549 to 2298 | 766 to 19 | tiling clone, AAA | 748/748 (100 %) | 3 diff (99.6 %id) | ||
BM973886 | lung | .d-u | 692 to 1291 | 618 to 19 | AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 600/600 (100 %) | 0 diff (100 %id) | |
BM973944 | lung | .a | 1295 to 2031 | 756 to 19 | AAA | 738/738 (100 %) | 2 diff (99.8 %id) | ||
BM975191 | lung | .a | 1108 to 1827 | 734 to 19 | AAA | 716/716 (100 %) | 7 diff (99.1 %id) | ||
CB851071 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 1089 to 1833 | 762 to 19 | AAA | 744/744 (100 %) | 5 diff (99.4 %id) | ||
CB851071 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 1089 to 1833 | 762 to 19 | AAA | 744/744 (100 %) | 5 diff (99.4 %id) | ||
CB305462 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 1415 to 2031 | 635 to 19 | AAA | 617/617 (100 %) | 3 diff (99.6 %id) | ||
CB305462 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 1415 to 2031 | 635 to 19 | AAA | 617/617 (100 %) | 3 diff (99.6 %id) | ||
CB241988 | Human Lung Epithelial cells, lung | .d-u | 1292 to 2003 | 728 to 17 | K18I | AAA | 712/713 (99 %) | 4 diff (99.5 %id) | |
CB241988 | Human Lung Epithelial cells, lung | .d-u | 1292 to 2003 | 728 to 17 | K18I | AAA | 712/713 (99 %) | 4 diff (99.5 %id) | |
CB250689 | Human Lung Epithelial cells, lung | .a | 1379 to 1838 | 478 to 19 | AAA | 460/469 (98 %) | 0 diff (100 %id) | ||
CB250689 | Human Lung Epithelial cells, lung | .a | 1379 to 1838 | 478 to 19 | AAA | 460/469 (98 %) | 0 diff (100 %id) | ||
BM713620 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1352 to 1706 | 1 to 357 | 357/357 (100 %) | 2 diff (99.5 %id) | |||
BM713620 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1352 to 1706 | 1 to 357 | 357/357 (100 %) | 2 diff (99.5 %id) | |||
BM718578 | eye, fetal eye | .d-u | 1664 to 2001 | 1 to 338 | AAA | 338/338 (100 %) | 0 diff (100 %id) | ||
BM718578 | eye, fetal eye | .d-u | 1664 to 2001 | 1 to 338 | AAA | 338/338 (100 %) | 0 diff (100 %id) | ||
CA414187 | Knee, Osteoarthritic Cartilage | .d-u | 1402 to 2001 | 615 to 16 | K18I | AAA | 600/600 (100 %) | 4 diff (99.4 %id) | |
CA414187 | Knee, Osteoarthritic Cartilage | .d-u | 1402 to 2001 | 615 to 16 | K18I | AAA | 600/600 (100 %) | 4 diff (99.4 %id) | |
CA431573 | cell lines, Enchondroma | .a | 1125 to 1827 | 716 to 19 | AAA | 698/698 (100 %) | 9 diff (98.8 %id) | ||
CA431573 | cell lines, Enchondroma | .a | 1125 to 1827 | 716 to 19 | AAA | 698/698 (100 %) | 9 diff (98.8 %id) | ||
CA428943 | Cell Line, Chondrosarcoma | .d-u | 1754 to 2003 | 266 to 17 | AAA | 250/252 (99 %) | 2 diff (99.3 %id) | ||
CA428943 | Cell Line, Chondrosarcoma | .d-u | 1754 to 2003 | 266 to 17 | AAA | 250/252 (99 %) | 2 diff (99.3 %id) | ||
CA429001 | Cell Line, Chondrosarcoma | .d-u | 1402 to 2001 | 615 to 16 | K18I | AAA | 600/600 (100 %) | 8 diff (98.7 %id) | |
CA429001 | Cell Line, Chondrosarcoma | .d-u | 1402 to 2001 | 615 to 16 | K18I | AAA | 600/600 (100 %) | 8 diff (98.7 %id) | |
CA429027 | Cell Line, Chondrosarcoma | .d-u | 462 to 1110 | 658 to 14 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 645/645 (100 %) | 3 diff (99.6 %id) | |
CA429027 | Cell Line, Chondrosarcoma | .d-u | 462 to 1110 | 658 to 14 | AAA | Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) | 645/645 (100 %) | 3 diff (99.6 %id) | |
BU629842 | cell lines, Chondrosarcoma | .d-u | 1282 to 2003 | 740 to 19 | K18I | AAA | 722/722 (100 %) | 7 diff (99.1 %id) | |
BU629842 | cell lines, Chondrosarcoma | .d-u | 1282 to 2003 | 740 to 19 | K18I | AAA | 722/722 (100 %) | 7 diff (99.1 %id) | |
BU633803 | cell lines, Chondrosarcoma | .a | 1072 to 1833 | 779 to 18 | AAA | 762/762 (100 %) | 0 diff (100 %id) | ||
BU633803 | cell lines, Chondrosarcoma | .a | 1072 to 1833 | 779 to 18 | AAA | 762/762 (100 %) | 0 diff (100 %id) | ||
CA748617 | Alveolar Macrophage, lung | .a | 1227 to 1833 | 625 to 19 | AAA | 607/607 (100 %) | 1 diff (99.9 %id) | ||
CA748617 | Alveolar Macrophage, lung | .a | 1227 to 1833 | 625 to 19 | AAA | 607/607 (100 %) | 1 diff (99.9 %id) | ||
U46388 | liver cell line, pancreatic cancer | .a | 6394 to 6758 | 13 to 380 | 368/383 (96 %) | 7 diff (98.2 %id) | |||
U46388 | liver cell line, pancreatic cancer | .a | 6394 to 6758 | 13 to 380 | 368/383 (96 %) | 7 diff (98.2 %id) | |||
BP380488 | .a | 37 to 662 | 1 to 624 | 624/888 (70 %) | 8 diff (99.1 %id) |
? | Gene Summary | Gene on genome | mRNA:.a, .b, .c, .d-u, .e-u | Alternative mRNAs features, proteins, introns, exons, sequences | Expression Tissue | Function, regulation, related genes CI |